Skip to main navigation
Investor Relations
Who We Are
Management
Board of Directors
Our Focus
Dismutase Mimetics
Reducing Oral Mucositis
Aiming to Increase Efficacy of Radiation Therapy
Our Pipeline
Avasopasem (GC4419)
Rucosopasem (GC4711)
Clinical Trials
Key Publications
Investors
IR Home
Press Releases
Events and Presentations
Stock Information
Corporate Governance
SEC Filings
Shareholder Services
Contact Us
Event Details
Galera at H.C. Wainwright BioConnect Conference
Jan 10, 2022 at 7:00 AM EST
Click here for webcast
